| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $30.3M | -9.8% | -14.1% |
| Cost of Revenue | $6.1M | -27.6% | -39.4% |
| Gross Profit | $24.2M | -3.8% | -3.9% |
| R&D Expense | $9.1M | -11.3% | +2.5% |
| SG&A Expense | $27.3M | -5.6% | +6.8% |
| Operating Income | -$12.2M | +13.0% | -32.0% |
| Interest Expense | $4K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29.6M | -26.6% | +77.2% |
| Short-term Investments | $197.9M | +5.7% | -10.2% |
| Accounts Receivable | $24.2M | -13.9% | -4.8% |
| Inventory | $28.9M | +15.5% | +33.6% |
| Current Assets | $283.9M | +0.0% | -1.0% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.4M | — | — |
| Capital Expenditures | $2.7M | — | — |
| Investing Cash Flow | $26.5M | — | — |
| Financing Cash Flow | $800K | — | — |
| Free Cash Flow | -$17.1M | — | — |
| -20.0% |
| -20.0% |
| Pre-tax Income | -$9.8M | +16.6% | -55.0% |
| Income Tax | $10K | -68.8% | -23.1% |
| Net Income | -$9.8M | +16.7% | -54.9% |
| EPS (Basic) | -$0.24 | +17.2% | -50.0% |
| EPS (Diluted) | -$0.24 | +17.2% | -50.0% |
| $308.5M |
| -0.2% |
| -0.6% |
| Current Liabilities | $22.3M | +9.4% | -1.5% |
| Total Liabilities | $32.6M | +5.1% | -1.9% |
| Stockholders' Equity | $276.0M | -0.7% | -0.5% |